James Rainbow, head of marketing UK for the firm, said: "We may well do it at some point, but it is not in the product line. We have not spent a lot of time talking about it."
It has been reported elsewhere that the main factor holding the firm back from launching a UK-domiciled version of the £42.4m Sicav is the risk aversion in markets at the moment.
Rainbow refuted this: "It is not so much a question of risk aversion, European equity flows have not been fantastic for a long time, which is not a great surprise. We would certainly need to see a more favourable environment for European equities, but we have a lot of products in that space and I do not think we are going to add to that in the immediate future."
What’s more he said the group had been active in launching onshore products in the first half of the year, with its third launch coming in June with the Managed Monthly High Income Fund and added that pace would not continue in Q3 and Q4.
In Q1 the Small Cap Discovery and Strategic Bond funds were launched in the UK.
Rainbow also pointed to the launch in March of the Schroder ISF European Total Return Fund for Nicholette MacDonald-Brown.
While this is a Luxembourg-domiciled fund, its equivalent in the Asian equity space, the Schroder ISF Asian Total Return Fund, has had significant inflows from UK fund buyers and Schroders hopes for the same kind of uptake of the European Total Return Fund.
Launched in 2007, the Asian TR Fund now has $1.6bn AUM.